Elixirr International plc (AIM:ELIX) acquired The Retearn Group Ltd for approximately £7.0 million on April 9, 2021. The maximum total consideration payable is £7.0 million. This consists of initial cash consideration of £2.15 million, a proposed issue of 543,939 ordinary shares of 0.005 pence each in the capital of Elixirr International plc, plus potential earn out payments of up to £0.65 million in cash and up to £2.05 million in new Ordinary Shares totalling a maximum of £2.7 million, contingent on Retearn achieving revenue growth and EBITDA margin targets in periods up to 30th June 2024. An additional cash payment will be made based on the working capital of Retearn at completion. The ordinary shares issued pursuant to the acquisition will be subject to the same restrictions as certain other shareholders of the Company, as described in the Company's IPO admission document. These restrictions consist of a lock-in arrangement until 8 July 2021 and limitations on the Ordinary Shares that each shareholder can sell in each of the following three years. Mark Wyllie (Chief Executive Officer), Simon Smith (Chief Operating Officer) and Lee Cotsford (Chief Financial Officer) will continue to lead the business following the acquisition. In the year ended June 30, 2020, The Retearn Group recorded revenue of £5.65 million and profit before tax of £0.92 million. The transaction is immediately earnings enhancing. Christopher Raggett, Simon Hicks, Kate Bannatyne, Alice Lane and Sunila De Silva of FinnCap Ltd acted as nominated adviser to Elixirr International. Elixirr International plc (AIM:ELIX) completed the acquisition of The Retearn Group Ltd on April 9, 2021.